p53 tumor suppressor gene: at the crossroads of molecular carcinogenesis, molecular epidemiology, and human risk assessment
- PMID: 11083100
- DOI: 10.1111/j.1749-6632.2000.tb06870.x
p53 tumor suppressor gene: at the crossroads of molecular carcinogenesis, molecular epidemiology, and human risk assessment
Abstract
The molecular archaeology of the mutation spectra of tumor suppressor genes generates hypotheses concerning the etiology and molecular pathogenesis of human cancer. The spectrum of somatic mutations in the p53 gene implicates environmental carcinogens and both endogenous agents and processes in the etiology of human cancer.
Similar articles
-
Tumor suppressor genes: at the crossroads of molecular carcinogenesis, molecular epidemiology and human risk assessment.Lung Cancer. 2001 Dec;34 Suppl 2:S7-15. doi: 10.1016/s0169-5002(01)00339-7. Lung Cancer. 2001. PMID: 11720736 Review.
-
p53 tumor suppressor gene: at the crossroads of molecular carcinogenesis, molecular epidemiology, and cancer risk assessment.Environ Health Perspect. 1996 May;104 Suppl 3(Suppl 3):435-9. doi: 10.1289/ehp.96104s3435. Environ Health Perspect. 1996. PMID: 8781359 Free PMC article. Review.
-
p53 mutation spectrum and load: the generation of hypotheses linking the exposure of endogenous or exogenous carcinogens to human cancer.Mutat Res. 1999 Jul 16;428(1-2):23-32. doi: 10.1016/s1383-5742(99)00028-9. Mutat Res. 1999. PMID: 10517975 Review.
-
TP53 mutation spectra and load: a tool for generating hypotheses on the etiology of cancer.IARC Sci Publ. 2004;(157):247-70. IARC Sci Publ. 2004. PMID: 15055300 Review.
-
Molecular epidemiology and carcinogenesis: endogenous and exogenous carcinogens.Mutat Res. 2000 Apr;462(2-3):311-22. doi: 10.1016/s1383-5742(00)00015-6. Mutat Res. 2000. PMID: 10767641 Review.
Cited by
-
Genetic and biochemical alterations in non-small cell lung cancer.Biochem Res Int. 2012;2012:940405. doi: 10.1155/2012/940405. Epub 2012 Aug 15. Biochem Res Int. 2012. PMID: 22928112 Free PMC article.
-
Non-steroidal anti-inflammatory drugs (NSAIDs) and breast cancer risk: differences by molecular subtype.Cancer Causes Control. 2011 Jul;22(7):965-75. doi: 10.1007/s10552-011-9769-9. Epub 2011 Apr 23. Cancer Causes Control. 2011. PMID: 21516318 Free PMC article.
-
Interaction between p53 codon 72 polymorphism and melanocortin 1 receptor variants on suntan response and cutaneous melanoma risk.Br J Dermatol. 2008 Aug;159(2):314-21. doi: 10.1111/j.1365-2133.2008.08624.x. Epub 2008 May 28. Br J Dermatol. 2008. PMID: 18510673 Free PMC article.
-
Genetic signature for human risk assessment: lessons from trichloroethylene.Environ Mol Mutagen. 2009 Jan;50(1):68-77. doi: 10.1002/em.20432. Environ Mol Mutagen. 2009. PMID: 19031419 Free PMC article. Review.
-
Perspectives on the chemical etiology of breast cancer.Environ Health Perspect. 2002 Feb;110 Suppl 1(Suppl 1):119-28. doi: 10.1289/ehp.02110s1119. Environ Health Perspect. 2002. PMID: 11834470 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous